6-ECDCA

FXR agonist

Catalog No. SIH-590

0 out of 5 based on 0 customer ratings
CAS No. 459789-99-2
Molecular Formula C26H44O4
SKU: SIH-590 Categories: ,

SIH-590-6-ECDCA-Chemical-Structure.png
Product Name 6-ECDCA
Description

FXR agonist

Purity >98% (TLC); NMR (Conforms)
CAS No. 459789-99-2
Molecular Formula C26H44O4
Molecular Weight 420.6
Field of Use Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

Properties

Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Agonist
Solubility May be dissolved in DMSO (50 mg/ml) and ethanol (30 mg/ml)
Source Synthetic
Appearance White powder
SMILES CCC1C2CC(CCC2(C3CCC4(C(C3C1O)CCC4C(C)CCC(=O)O)C)C)O
InChI InChI=1S/C26H44O4/c1-5-17-21-14-16(27)10-12-26(21,4)20-11-13-25(3)18(15(2)6-9-22(28)29)7-8-19(25)23(20)24(17)30/h15-21,23-24,27,30H,5-14H2,1-4H3,(H,28,29)/t15-,16-,17-,18-,19+,20+,21+,23+,24-,25-,26-
InChIKey ZXERDUOLZKYMJM-ZWECCWDJSA-N
Safety Phrases Classification:
Not a hazardous substance or mixture.

Safety Phrases:
S22 - Do not breathe dust.
S24/25 - Avoid contact with skin and eyes.
S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.
Cite This Product 6-ECDCA (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-590)

Biological Description

Alternative Names 6-Ethylchenodeoxycholic acid; 3α,7α-Dihydroxy-6α-ethyl-5β-cholan-24-oic acid; Obeticholic acid
Research Areas Apoptosis, Cancer
PubChem ID 447715
Scientific Background 6-ECDCA or Obeticholic acid, is a potent, selective and orally active FXR agonist. It has anticholeretic and anti-inflammation effects, and also induces autophagy.

Product Images

<p>Chemical structure of 6-ECDCA (SIH-590), a FXR Agonist. CAS #: 459789-99-2. Molecular Formula: C26H44O4. Molecular Weight: 420.6 g/mol.</p>

Chemical structure of 6-ECDCA (SIH-590), a FXR Agonist. CAS #: 459789-99-2. Molecular Formula: C26H44O4. Molecular Weight: 420.6 g/mol.

Reviews

Reviews

There are no reviews yet.

Be the first to review “6-ECDCA”

Your email address will not be published. Required fields are marked *